Displaying archives for 2014 June:

Feds fund lung cancer research at New York Medical College

Posted by Samantha Powell on June 30th, 2014 |

New York Medical College in Valhalla has been awarded a $201,250 grant to study lung cancer formation and growth triggered by nickel compounds. The award from the National Institutes of Health was recently announced by U.S. Rep. Nita M. Lowey, the senior Democrat on the House Appropriations Committee from the 17th congressional district in Westchester […]

Larger Studies of Multiple Families Will Help Us Better Understand Inherited Risk of Lung Cancer.

Posted by Samantha Powell on June 27th, 2014 |

Larger Studies of Multiple Families Will Help Us Better Understand Inherited Risk of Lung Cancer.

Lung cancer study of why young, healthy are stricken

Posted by Samantha Powell on June 24th, 2014 |

Natalie DiMarco’s only obvious risk factor for getting lung cancer was having lungs. DiMarco had been experiencing respiratory problems for months in 2010, but her doctors just assumed the mother of two had allergies. By the time she learned she had lung cancer, the disease had spread into her lymph nodes and reached the membranes […]

Ambitious ‘Lung-MAP’ Trial Aims to Evaluate Biomarkers and New Drugs in Squamous Cell Lung Cancer

Posted by Samantha Powell on June 23rd, 2014 |

This month, the National Cancer Institute (NCI), along with the FDA, the Southwest Oncology Group (SWOG), several private foundations and five pharmaceutical companies, launched a prospective, biomarker-driven study of new drugs for squamous cell lung cancer. The Lung-MAP trial is remarkable for its collaborative nature, and scope. The study will identify “actionable” molecular abnormalities in […]

Not just smokers: Every woman is at risk for lung cancer

Posted by Samantha Powell on June 23rd, 2014 |

Every five minutes, a woman in the United States is diagnosed with lung cancer, including nearly 2,000 this year from Arizona. Half of these women will not be alive a year later, and two-thirds of women diagnosed never smoked or are former smokers. The American Lung Association is racing against the clock to save women’s […]

Damon Runyon Cancer Research foundation awards $4M to 10 top young clinical investigators

Posted by Samantha Powell on June 23rd, 2014 |

The Damon Runyon Cancer Research Foundation named seven new Damon Runyon Clinical Investigators at its spring 2014 Clinical Investigator Award Committee review. The recipients of this prestigious three-year award are outstanding early career physician-scientists conducting patient-oriented cancer research at major research centers under the mentorship of the nation’s leading scientists and clinicians. Each will receive […]

Johnson & Johnson Innovation Announces Immuno-Oncology Lung Cancer Collaboration with the Dana-Farber Cancer Institute’s Belfer Institute for Applied Cancer Science

Posted by Samantha Powell on June 23rd, 2014 |

Johnson & Johnson Innovation, Boston and Janssen Biotech, Inc. today announced a three-year immuno-oncology lung cancer collaboration with the Dana-Farber Cancer Institute. Through the collaboration, Janssen scientists will work with the research team at Dana-Farber’s Belfer Institute for Applied Cancer Science to determine the clinical setting for certain immuno-oncology agents in Janssen’s lung cancer discovery […]

Woman survives scary lung cancer diagnosis and finds new life’s work

Posted by Samantha Powell on June 22nd, 2014 |

Six months to live. Mary Jo Grand sat in the sterile exam room. The tumors spat out by her undiagnosed lung cancer had lit up the PET scan — dense black splotches throughout her lungs and arms and abdomen and neck and chest. The doctor was talking. Grim, horrible statistics. Treatment. Experimental medicine. Grand hadn’t […]

Cancer Doctors Ring Up Big Medicare Bills for Tarnished Drug Procrit

Posted by Samantha Powell on June 19th, 2014 |

Many cancer doctors now use a drug called Procrit sparingly. It was approved in 1989 for anemia and became a popular treatment for that side effect of chemotherapy. But regulators later learned Procrit can speed tumor growth and hasten death in cancer patients. Today, use of this class of drug—best known as EPO, a substance […]

OncLive to Host “Giants of Cancer Care” Celebration Event in New York City

Posted by Samantha Powell on June 18th, 2014 |

The 2014 Giants of Cancer Care are here, and tomorrow OncLive will host a special celebration event in New York City to honor the three Big Apple-based members of this year’s class of Giants. The reception, which will feature remarks from OncLive representatives, local Giants and other industry leaders, will be held at the Sheraton […]